Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entyvio post-marketing drug-use survey in Crohn's disease
jRCT1080224753Completed
- Sponsor
- Takeda
- Start
- Jun 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of vedolizumab in Crohn's disease, sponsored by Takeda. Started Jun 2019; status: completed.
02
Drugs
vedolizumab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on jRCT1080224753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224753.